- Diagnostics
- Thursday, 13 Feb 2020
DERMALOG Provides the World's First Biometric Border Control System With Integrated Fever Detection
As the first country in the world, Thailand has introduced a pilot for a new fever detection system, fully integrated into its biometric border control. The new solution was demonstrated to the press by the Thai Immigration Bureau deputy commissioner, Pol Maj-Gen Surapong Chaichan at Don Mueang International Airport in Bangkok on February 12.
From now on, the biometric border control system in Don Mueang can capture not only fingerprints and faces, but also measures the body temperature of travelers who pass through the related counters. The temperature is displayed on the border officer's screen and, if someone with fever is detected, the officer is automatically informed and can send the affected person for a health check.
DERMALOG, the supplier of the biometric border control system, has developed a special fever camera, which is fully integrated into the Thai entry-exit system. It automatically measures the exact temperature of the traveler while standing in front of the border counter. The high fever-detection accuracy at a distance of up to 1.5 m, is one of the system's outstanding features.
Border counters are the perfect spot for such fever checks, as travelers stop here one by one for a moment. DERMALOG's solution provides more accurate and precise results than camera systems that capture several travelers simultaneously. This makes the Thai borders more secure, also against the coronavirus.
Related Industry Updates
Phosphorus Announces In-Home COVID-19 Viral And Antibody Testing Service In New York Metropolitan Area
May 19, 2020
Animal Health Market to Register Steady Expansion During 2020-2027 BY Merck & Co., Inc. ,BoehringerIngelheim International GmbH ,Ceva Santé Animale ,Cargill, Incorporated
Mar 30, 2021
Novacyt and Yourgene Healthcare companies to produce coronavirus test products in UK
Mar 25, 2020
North America Cancer tissue diagnostics market is expected to reach US$ 4,350 million by 2027 with CAGR of 8%.
Oct 20, 2020
Huami partners with Nanshan Zhong's team to fight COVID-19 coronavirus in a joint laboratory
Apr 13, 2020
$4.6m Awarded for Clinical Trials at Northwell's Cancer Institute
Oct 16, 2019
Mako Medical Expands COVID-19 Testing to Help Those on the Front Lines
Apr 20, 2020